Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Edwards Lifesciences Corp (NYSE:EW)

120.26
BATS BZX Real-Time Price
As of 1:38pm ET
 +1.00 / +0.84%
Today’s Change
69.22
Today|||52-Week Range
121.73
+52.27%
Year-to-Date
7 Healthcare Stocks in Focus on World Heart Day
Sep 29 / Zacks.com - Paid Partner Content
AngioDynamics Hits New 52-Week High on Solid Q4 Results
Sep 22 / Zacks.com - Paid Partner Content
How Chart Analysis Tops Fundamental Analysis
Sep 23 / TheStreet.com - Paid Partner Content
Edwards Lifesciences, DaVita HealthCare Partners, Corcept Therapeutics and CryoLife h...
Sep 22 / Zacks.com - Paid Partner Content
athenahealth Unveils athenaInsight, Focuses on Opioid Abuse
Sep 22 / Zacks.com - Paid Partner Content
Bull of the Day: Edwards Lifesciences (EW)
Sep 22 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close119.26
Today’s open119.87
Day’s range119.45 - 120.80
Volume41,684
Average volume (3 months)1,364,211
Market cap$25.4B
Dividend yield--
Data as of 1:38pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)-39.84%
Earnings growth (this year)+25.77%
Earnings growth (next 5 years)+17.50%
Revenue growth (last year)+7.35%
P/E ratio49.7
Price/Sales6.98
Price/Book10.26

Competitors

 Today’s
change
Today’s
% change
ISRGIntuitive Surgical+3.61+0.50%
SNNSmith & Nephew PLC+0.37+1.14%
SYKStryker Corp+0.42+0.36%
STESTERIS plc+0.51+0.70%
Data as of 1:39pm ET, 09/30/2016

Financials

Next reporting dateOctober 24, 2016
EPS forecast (this quarter)$0.68
Annual revenue (last year)$2.5B
Annual profit (last year)$494.9M
Net profit margin19.85%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Michael A. Mussallem
Chief Financial Officer &
Vice President
Scott B. Ullem
Corporate headquarters
Irvine, California

Forecasts

Search for Jobs